- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial
- Study type descriptors: Interventional, Single centre
- Study aim: To determine the effect of Pycnogenol versus placebo on patient-reported health status in people with long COVID-19
- Number of participants enrolled: 153
- Study enrolling from to
- Study includes follow-up for 3 months
Study Data
- General population
- Elderly
- Adult
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Pycnogenol
External Links
Other information
Funders/Sponsors:
- Horphag Research, Av. Louis-Casaï, 1216 Cointrin, Switzerland
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to